Clinical Trial Update: Efficacy and Safety of Serplulimab Combined With Etoposide and Cisplatin as Neoadjuvant Therapy in Limited-Stage Small-Cell Carcinoma of the Esophageal [Phase 2]

View source ↗

Summary

This is a Phase 2 neoadjuvant trial evaluating serplulimab plus etoposide and cisplatin for limited-stage small-cell carcinoma of the esophagus; the study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small-cell Carcinoma of the Esophagus

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Serplulimab (serplulimab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Small-Cell Carcinoma of the Esophageal | Phase 2 | Status: NOT_YET_RECRUITING